Want to see JP:4521 full AI Analyst Report?

Kaken Pharmaceutical Co (4521) Revenue

0 Followers

Kaken Pharmaceutical Co Revenue

Kaken Pharmaceutical Co had a revenue of 18.05B in the quarter ending Mar 31, 2026, with -26.70%. This bring the company's revenue in the last twelve months to 94.03B, Decreased 0.73%. In the fiscal year ending Mar 31, 2026, Kaken Pharmaceutical Co had annual revenue of 94.03B with 22.33% growth.

Revenue (ttm)

94.03B

Revenue Growth

-18.25%

P/S Ratio

1.48

Revenue/Employee

¥84,412,029

Employees

1,114

Market Cap

¥139.57B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2026	94.03B	17.16B	+22.33%
Mar 31, 2026	76.87B	4.83B	+6.70%
Mar 31, 2025	72.04B	-940.00M	-1.29%
Mar 31, 2024	72.98B	-3.05B	-4.01%
Mar 31, 2023	76.03B	1.05B	+1.41%
Mar 31, 2022	74.98B	-14.26B	-15.97%
Mar 31, 2021	89.23B	-4.93B	-5.24%
Mar 31, 2020	94.17B	-4.26B	-4.33%
Mar 31, 2019	98.43B	-3.56B	-3.49%
Mar 31, 2017	101.99B	―	―